Management

from left to right: Volker Jenzelewski, Michael Weniger, Ruth Maas, Melanie Piontek, Michael Piontek

Dr. Michael Piontek (Managing Director)

Michael Piontek is founder of ARTES and Managing Director. He has more than 20 years experience in contract R&D, process development and company management. Formerly he was Head of Process Development and Managing Director at Rhein Biotech GmbH. In this time, he was responsible for process and product development as well as for technology transfer of production processes in Europe, Asia, South America and North Africa.

P: +49 (0) 2173 27587-11
M: +49 (0) 173 213 26 15
E: michael.piontek(at)artes-biotechnology.com

Dr. Melanie Piontek (Business Development Director)

Melanie Piontek holds a PhD in biology and is specialized in protein chemistry. She is in charge of business development for ARTES since 2006. Before that, she worked 8 years in regional development companies and technology transfer agencies with the focus on supplying biotech companies with marketing and networking opportunities, as well as with business development support.

P: +49 (0) 2173 27587–12
M: +49 (0) 177 501 47 48
E: melanie.piontek(at)artes-biotechnology.com

Dipl.-Biol. Volker Jenzelewski (Director Technology)

Volker Jenzelewski holds a degree in biology and started his professional career in 1993 at RheinBiotech GmbH. Assuming positions of increasing responsibility in technical management and GMP-manufacturing he was finally directing process development and heading GMP manufacturing. In 2010 he stepped into the field of advanced therapy medicinal products as Managing Director of EUFETS GmbH, an internationally operating CDMO. In 2014 he joined ARTES Biotechnology GmbH as Director of Technology.

P: +49 (0) 2173 27587 -19

M: + 49 (0) 152 54715382
E: volker.jenzelewski(at)artes-biotechnology.com

Dipl.-Ing. Michael Weniger (Head of Process Development)

Michael Weniger holds a degree as Graduate Engineer Biotechnology/Biochemistry. Formerly he was Project Leader and Senior Engineer Process Development at Rhein Biotech GmbH. He was involved in successful technology transfer of cGMP production processes to South America, Korea and Egypt.

His experience are in the field of up- and downstream processing of bacterial processes, optimization of fermentation processes with subsequent development of protein isolation and purification strategies until generation of purified final bulk. He has experience in cGMP production of a Phase IIIa product and deep know how in qualification (DQ/IQ/OQ) and validation (PQ, cleaning validation) of equipment and process with the appropriate cGMP documentation.

P: +49 (0) 2173 27587 -20
E: michael.weniger(at)artes-biotechnology.com

Dr. Ruth Maas (Head of Molecular Biology)

Dr. Ruth Maas joined ARTES in May 2020 and since September this year she is heading the department of Molecular Biology. Ruth Maas holds a PhD from the Department of Microbiology/Biotechnology of the University Tübingen and has almost 30 years of experience with recombinant expression technologies in different microbial host systems. Before joining ARTES, she was involved as a Cofounder and Manager in various positions in two biotechnology start-up companies, Pharmacelsus GmbH and Autodisplay Biotech GmbH.

P: +49 (0) 2173 27587 -15
E: ruth.maas(at)artes-biotechnology.com

Dipl.-Ing. Petra Zimmer (Finance Director)

Petra Zimmer is in charge of finances for ARTES. She is qualified as tax-advisor and runs her own business since more than 20 years, mainly with clients from the biotech branch. In between she has been full-time Chief Financial Officer of Rhein Biotech GmbH for five years. She holds a Master Degree in Machinery Construction and started her business experience with Arthur Andersen where she left as Manager.

P: +49 (0) 2173 27587 -22
E: petra.zimmer(at)artes-biotechnology.com